BindingDB logo
myBDB logout

Patent code US10882853

Compile Data Set for Download or QSAR
Found 12 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Hepatocyte growth factor receptor


(Homo sapiens (Human))
BDBM50399540
PNG
(FORETINIB | US10464902, Foretinib | US10882853, Co...)
Show SMILES COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1
Show InChI InChI=1S/C34H34F2N4O6/c1-43-30-20-25-27(21-31(30)45-16-2-13-40-14-17-44-18-15-40)37-12-9-28(25)46-29-8-7-24(19-26(29)36)39-33(42)34(10-11-34)32(41)38-23-5-3-22(35)4-6-23/h3-9,12,19-21H,2,10-11,13-18H2,1H3,(H,38,41)(H,39,42)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
antibodypedia
GoogleScholar
Purchase

MMDB
PC cid
PC sid
PDB
UniChem

Similars

PDB
US Patent
n/an/a 2.91n/an/an/an/an/an/a



LaNova Medicines Limited

US Patent


Assay Description
1. Methods(1) 4 μL of prepared kinase buffer solution or 4 μL of kinase solution (100% inhibition control) were added into a 384-hole plate...


US Patent US10882853 (2021)

More data for this
Ligand-Target Pair
3D
3D Structure (crystal)
Hepatocyte growth factor receptor


(Homo sapiens (Human))
BDBM477046
PNG
(US10882853, Compound 15)
Show SMILES COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3F)ccnc2cc1OCC(F)(F)CN1CCOCC1
Show InChI InChI=1S/C34H32F4N4O6/c1-45-29-17-24-26(18-30(29)47-20-34(37,38)19-42-12-14-46-15-13-42)39-11-8-27(24)48-28-7-6-23(16-25(28)36)41-32(44)33(9-10-33)31(43)40-22-4-2-21(35)3-5-22/h2-8,11,16-18H,9-10,12-15,19-20H2,1H3,(H,40,43)(H,41,44)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 6.64n/an/an/an/an/an/a



LaNova Medicines Limited

US Patent


Assay Description
1. Methods(1) 4 μL of prepared kinase buffer solution or 4 μL of kinase solution (100% inhibition control) were added into a 384-hole plate...


US Patent US10882853 (2021)

More data for this
Ligand-Target Pair
Hepatocyte growth factor receptor


(Homo sapiens (Human))
BDBM477041
PNG
(US10882853, Compound Foretinib)
Show SMILES COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)ccnc2cc1OCCCN1CCOCC1
Show InChI InChI=1S/C34H35FN4O6/c1-42-30-21-27-28(22-31(30)44-18-2-15-39-16-19-43-20-17-39)36-14-11-29(27)45-26-9-7-25(8-10-26)38-33(41)34(12-13-34)32(40)37-24-5-3-23(35)4-6-24/h3-11,14,21-22H,2,12-13,15-20H2,1H3,(H,37,40)(H,38,41)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 7.49n/an/an/an/an/an/a



LaNova Medicines Limited

US Patent


Assay Description
1. Methods(1) 4 μL of prepared kinase buffer solution or 4 μL of kinase solution (100% inhibition control) were added into a 384-hole plate...


US Patent US10882853 (2021)

More data for this
Ligand-Target Pair
Vascular endothelial growth factor receptor 2


(Homo sapiens (Human))
BDBM50399540
PNG
(FORETINIB | US10464902, Foretinib | US10882853, Co...)
Show SMILES COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1
Show InChI InChI=1S/C34H34F2N4O6/c1-43-30-20-25-27(21-31(30)45-16-2-13-40-14-17-44-18-15-40)37-12-9-28(25)46-29-8-7-24(19-26(29)36)39-33(42)34(10-11-34)32(41)38-23-5-3-22(35)4-6-23/h3-9,12,19-21H,2,10-11,13-18H2,1H3,(H,38,41)(H,39,42)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
Purchase

MMDB
PC cid
PC sid
PDB
UniChem

Similars

US Patent
n/an/a 10.6n/an/an/an/an/an/a



LaNova Medicines Limited

US Patent


Assay Description
1. Methods(1) 4 μL of prepared kinase buffer solution or 4 μL of kinase solution (100% inhibition control) were added into a 384-hole plate...


US Patent US10882853 (2021)

More data for this
Ligand-Target Pair
Vascular endothelial growth factor receptor 2


(Homo sapiens (Human))
BDBM477041
PNG
(US10882853, Compound Foretinib)
Show SMILES COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)ccnc2cc1OCCCN1CCOCC1
Show InChI InChI=1S/C34H35FN4O6/c1-42-30-21-27-28(22-31(30)44-18-2-15-39-16-19-43-20-17-39)36-14-11-29(27)45-26-9-7-25(8-10-26)38-33(41)34(12-13-34)32(40)37-24-5-3-23(35)4-6-24/h3-11,14,21-22H,2,12-13,15-20H2,1H3,(H,37,40)(H,38,41)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 14.8n/an/an/an/an/an/a



LaNova Medicines Limited

US Patent


Assay Description
1. Methods(1) 4 μL of prepared kinase buffer solution or 4 μL of kinase solution (100% inhibition control) were added into a 384-hole plate...


US Patent US10882853 (2021)

More data for this
Ligand-Target Pair
Hepatocyte growth factor receptor


(Homo sapiens (Human))
BDBM477048
PNG
(US10882853, Compound 33)
Show SMILES COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3F)ccnc2cc1OCCN1CC(C1)N1CCOCC1
Show InChI InChI=1S/C36H37F2N5O6/c1-46-32-19-27-29(20-33(32)48-17-12-42-21-26(22-42)43-13-15-47-16-14-43)39-11-8-30(27)49-31-7-6-25(18-28(31)38)41-35(45)36(9-10-36)34(44)40-24-4-2-23(37)3-5-24/h2-8,11,18-20,26H,9-10,12-17,21-22H2,1H3,(H,40,44)(H,41,45)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 15n/an/an/an/an/an/a



LaNova Medicines Limited

US Patent


Assay Description
1. Methods(1) 4 μL of prepared kinase buffer solution or 4 μL of kinase solution (100% inhibition control) were added into a 384-hole plate...


US Patent US10882853 (2021)

More data for this
Ligand-Target Pair
Hepatocyte growth factor receptor


(Homo sapiens (Human))
BDBM477044
PNG
(US10882853, Compound 10)
Show SMILES COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3F)ccnc2cc1OC1CC(C1)N1CCOCC1
Show InChI InChI=1S/C35H34F2N4O6/c1-44-31-19-26-28(20-32(31)46-25-17-24(18-25)41-12-14-45-15-13-41)38-11-8-29(26)47-30-7-6-23(16-27(30)37)40-34(43)35(9-10-35)33(42)39-22-4-2-21(36)3-5-22/h2-8,11,16,19-20,24-25H,9-10,12-15,17-18H2,1H3,(H,39,42)(H,40,43)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 17n/an/an/an/an/an/a



LaNova Medicines Limited

US Patent


Assay Description
1. Methods(1) 4 μL of prepared kinase buffer solution or 4 μL of kinase solution (100% inhibition control) were added into a 384-hole plate...


US Patent US10882853 (2021)

More data for this
Ligand-Target Pair
Hepatocyte growth factor receptor


(Homo sapiens (Human))
BDBM477045
PNG
(US10882853, Compound 5)
Show SMILES COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3F)ccnc2cc1OCC1CC(C1)N1CCOCC1
Show InChI InChI=1S/C36H36F2N4O6/c1-45-32-19-27-29(20-33(32)47-21-22-16-26(17-22)42-12-14-46-15-13-42)39-11-8-30(27)48-31-7-6-25(18-28(31)38)41-35(44)36(9-10-36)34(43)40-24-4-2-23(37)3-5-24/h2-8,11,18-20,22,26H,9-10,12-17,21H2,1H3,(H,40,43)(H,41,44)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 20.6n/an/an/an/an/an/a



LaNova Medicines Limited

US Patent


Assay Description
1. Methods(1) 4 μL of prepared kinase buffer solution or 4 μL of kinase solution (100% inhibition control) were added into a 384-hole plate...


US Patent US10882853 (2021)

More data for this
Ligand-Target Pair
Hepatocyte growth factor receptor


(Homo sapiens (Human))
BDBM477047
PNG
(US10882853, Compound 24)
Show SMILES COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3F)ccnc2cc1OCC1C[C@H]1CN1CCOCC1
Show InChI InChI=1S/C36H36F2N4O6/c1-45-32-18-27-29(19-33(32)47-21-23-16-22(23)20-42-12-14-46-15-13-42)39-11-8-30(27)48-31-7-6-26(17-28(31)38)41-35(44)36(9-10-36)34(43)40-25-4-2-24(37)3-5-25/h2-8,11,17-19,22-23H,9-10,12-16,20-21H2,1H3,(H,40,43)(H,41,44)/t22-,23?/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 25.2n/an/an/an/an/an/a



LaNova Medicines Limited

US Patent


Assay Description
1. Methods(1) 4 μL of prepared kinase buffer solution or 4 μL of kinase solution (100% inhibition control) were added into a 384-hole plate...


US Patent US10882853 (2021)

More data for this
Ligand-Target Pair
Vascular endothelial growth factor receptor 2


(Homo sapiens (Human))
BDBM477045
PNG
(US10882853, Compound 5)
Show SMILES COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3F)ccnc2cc1OCC1CC(C1)N1CCOCC1
Show InChI InChI=1S/C36H36F2N4O6/c1-45-32-19-27-29(20-33(32)47-21-22-16-26(17-22)42-12-14-46-15-13-42)39-11-8-30(27)48-31-7-6-25(18-28(31)38)41-35(44)36(9-10-36)34(43)40-24-4-2-23(37)3-5-24/h2-8,11,18-20,22,26H,9-10,12-17,21H2,1H3,(H,40,43)(H,41,44)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 39.9n/an/an/an/an/an/a



LaNova Medicines Limited

US Patent


Assay Description
1. Methods(1) 4 μL of prepared kinase buffer solution or 4 μL of kinase solution (100% inhibition control) were added into a 384-hole plate...


US Patent US10882853 (2021)

More data for this
Ligand-Target Pair
Vascular endothelial growth factor receptor 2


(Homo sapiens (Human))
BDBM477044
PNG
(US10882853, Compound 10)
Show SMILES COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3F)ccnc2cc1OC1CC(C1)N1CCOCC1
Show InChI InChI=1S/C35H34F2N4O6/c1-44-31-19-26-28(20-32(31)46-25-17-24(18-25)41-12-14-45-15-13-41)38-11-8-29(26)47-30-7-6-23(16-27(30)37)40-34(43)35(9-10-35)33(42)39-22-4-2-21(36)3-5-22/h2-8,11,16,19-20,24-25H,9-10,12-15,17-18H2,1H3,(H,39,42)(H,40,43)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 64.2n/an/an/an/an/an/a



LaNova Medicines Limited

US Patent


Assay Description
1. Methods(1) 4 μL of prepared kinase buffer solution or 4 μL of kinase solution (100% inhibition control) were added into a 384-hole plate...


US Patent US10882853 (2021)

More data for this
Ligand-Target Pair
Hepatocyte growth factor receptor


(Homo sapiens (Human))
BDBM477043
PNG
(US10882853, Compound For-Methyl)
Show SMILES COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)c(F)c4)cc3F)ccnc2cc1OCCC[N+]1(C)CCOCC1
Show InChI InChI=1S/C35H35F3N4O6/c1-42(13-16-46-17-14-42)12-3-15-47-32-21-28-24(20-31(32)45-2)29(8-11-39-28)48-30-7-5-23(19-27(30)38)41-34(44)35(9-10-35)33(43)40-22-4-6-25(36)26(37)18-22/h4-8,11,18-21H,3,9-10,12-17H2,1-2H3,(H-,40,41,43,44)/p+1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 163n/an/an/an/an/an/a



LaNova Medicines Limited

US Patent


Assay Description
1. Methods(1) 4 μL of prepared kinase buffer solution or 4 μL of kinase solution (100% inhibition control) were added into a 384-hole plate...


US Patent US10882853 (2021)

More data for this
Ligand-Target Pair
* indicates data uncertainty>20%